UPDATE : Friday, July 19, 2019
상단여백
Government employee stages one-person protest against own ministry by Lee Hye-seon 2019-07-18 17:07
Ministry extends data submission for cell therapy CureSkin by Lee Hye-seon 2019-07-15 14:35
Ministry to request investigation into Meditoxin approval process by Lee Hye-seon 2019-07-12 16:29
Acute renal failure reported in ibandronate injections by Lee Hye-seon 2019-07-11 13:34
Pfizer fails to cut participants in Xeljanz’ post-marketing surveillance by Lee Hye-seon 2019-07-08 16:39
라인
Kolon confident to resume US trial on Invossa by Lee Hye-seon 2019-07-04 14:05
Regulator revokes Invossa license; Kolon CEO ‘to fight in court’ by Lee Hye-seon 2019-07-03 11:52
26 new drugs approved in H1 by Lee Hye-seon 2019-07-02 14:31
Multinationals face suspension of drug imports by Lee Hye-seon 2019-07-01 14:12
Government to help cover costs for injuries from side effects by Lee Hye-seon 2019-06-28 12:30
라인
Samsung Bioepis readies phase-3 trial on Soliris biosimilar by Lee Hye-seon 2019-06-27 17:14
False ads of ‘hair loss treatments’ got caught by Lee Hye-seon 2019-06-27 16:42
Voluntary nullifications of drug license tripled in H1 by Lee Hye-seon 2019-06-26 14:25
Celltrion denies delay in local license application for HIV drug Temixys by Lee Hye-seon 2019-06-25 10:56
Anti-cancer Sutene could cause central nervous system abnormality in fetus by Lee Hye-seon 2019-06-24 11:35
라인
LSK Global PS wins international recognition in clinical data management by Lee Hye-seon 2019-06-13 14:30
Daewoong joins fray to develop rheumatoid arthritis drug by Lee Hye-seon 2019-06-07 11:29
Regulator faces serious repercussions after Invossa debacle by Lee Hye-seon 2019-05-29 14:50
Invossa poses almost no safety threat: regulator by Lee Hye-seon 2019-05-28 16:02
Gore agrees to supply more artificial blood vessels for children by Lee Hye-seon 2019-05-24 12:53
여백
여백
여백
Back to Top